Table 3.
Basic recommendations for health care of physicians involved in the management of patients with advanced PD during evaluation of clinical and surgical emergencies.
| 1: never stop the use of levodopa abruptly |
| 2: change on levodopa regimen (dose and intervals of administration) should only be done in specific situations following recommendations of a specialist |
| 3: avoid the infusion of levodopa along the administration of enteral diet |
| 4: avoid the use of typical neuroleptics |
| 5: when use of neuroleptics is unavoidable, clozapine and quetiapine are the safer options |
| 6: avoid the use of drugs with potential antidopaminergic effect (neuroleptics and antiemetics) |
| 7: if GI prokinetic drugs are necessary, give preference to domperidone |
| 8: be vigilant for drug interactions in elderly patients with PD and different comorbidities |
| 9: as a last resort, dispersible levodopa may be used, sublingually |
| 10: subcutaneous apomorphine can be used as a rescue medication, when available |
| 11: if medication regimen needs to be adjusted, preference should be given to less essential drugs, such as MAO B inhibitors, dopamine agonists, and amantadine, preferably under the guidance of a specialist |
| 12: anticholinergics should be strongly avoided to be used in this group of patients |